Javier Pizarro-Berdichevsky1,2,3, Ali Borazjani4,5, Alejandro Pattillo6,7, Marco Arellano6, Jianbo Li8, Howard B Goldman9. 1. Urogynecology Unit, H. Dr. Sotero del Rio, Santiago, Chile. jpizarro@med.puc.cl. 2. Division Obstetricia y Ginecologia, Pontificia Universidad Católica de Chile, Lira 85, 5to piso, Santiago, Chile. jpizarro@med.puc.cl. 3. Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. jpizarro@med.puc.cl. 4. Department of Biomedical Engineering, Cleveland Clinic, Cleveland, OH, USA. 5. Global Innovations for Reproductive Health & Life, Cleveland, OH, USA. 6. Urogynecology Unit, H. Dr. Sotero del Rio, Santiago, Chile. 7. Division Obstetricia y Ginecologia, Pontificia Universidad Católica de Chile, Lira 85, 5to piso, Santiago, Chile. 8. Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA. 9. Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Abstract
INTRODUCTION AND HYPOTHESIS: At our institution many symptomatic patients must wait months or years for surgery. Our aim was to determine the rates of clinically significant pelvic organ prolapse (POP) progression and identify risk factors associated with POP progression. METHODS: Data from a prospectively maintained database of POP patients evaluated between 2008 and 2013 were analyzed. Women with symptomatic POP and two or more POP-Q examinations prior to surgery were included. POP progression was defined as having any of the POP-Q points Aa, Ba, C, D, Ap or Bp above the hymen at the baseline examination and at or below the hymen at the follow-up examination. Multivariable logistic analysis was preformed and the results are presented as odds ratios (OR) with 95% confidence intervals (CI). RESULTS: Of consecutive patients evaluated between July 2008 and June 2013, 388 met the inclusion criteria and were included. The median time between the POP-Q examinations was 9.9 months (IQR 7.8 to 13.8 months). The POP progression rate was 29.1% (95% CI 24.6-33.6%). Predictors of progression included age (OR 1.7, 95% CI 1.01-2.87) and the baseline status of points Ba, C, Bp and gH (OR 1.91, 95% CI 1.01-3.62; OR 0.53, 95% CI 0.3-0.94; OR 0.54, 95% CI 0.32-0.93; OR 2.15, 95% CI 1.13-4.1; respectively). POP-Q point correlations showed that anterior and posterior compartment points evolve with apical compartment points and gH evolves with both the anterior compartment and the apex. CONCLUSIONS: Up to 29.1% of symptomatic patients with POP showed clinically significant progression over a median follow-up of 9.9 months. The likelihood of progression was not significantly associated with time. Those ≥60 years of age as well as those with point Ba ≥4 cm or gH ≥5 cm at baseline were at increased risk of POP progression.
INTRODUCTION AND HYPOTHESIS: At our institution many symptomatic patients must wait months or years for surgery. Our aim was to determine the rates of clinically significant pelvic organ prolapse (POP) progression and identify risk factors associated with POP progression. METHODS: Data from a prospectively maintained database of POP patients evaluated between 2008 and 2013 were analyzed. Women with symptomatic POP and two or more POP-Q examinations prior to surgery were included. POP progression was defined as having any of the POP-Q points Aa, Ba, C, D, Ap or Bp above the hymen at the baseline examination and at or below the hymen at the follow-up examination. Multivariable logistic analysis was preformed and the results are presented as odds ratios (OR) with 95% confidence intervals (CI). RESULTS: Of consecutive patients evaluated between July 2008 and June 2013, 388 met the inclusion criteria and were included. The median time between the POP-Q examinations was 9.9 months (IQR 7.8 to 13.8 months). The POP progression rate was 29.1% (95% CI 24.6-33.6%). Predictors of progression included age (OR 1.7, 95% CI 1.01-2.87) and the baseline status of points Ba, C, Bp and gH (OR 1.91, 95% CI 1.01-3.62; OR 0.53, 95% CI 0.3-0.94; OR 0.54, 95% CI 0.32-0.93; OR 2.15, 95% CI 1.13-4.1; respectively). POP-Q point correlations showed that anterior and posterior compartment points evolve with apical compartment points and gH evolves with both the anterior compartment and the apex. CONCLUSIONS: Up to 29.1% of symptomatic patients with POP showed clinically significant progression over a median follow-up of 9.9 months. The likelihood of progression was not significantly associated with time. Those ≥60 years of age as well as those with point Ba ≥4 cm or gH ≥5 cm at baseline were at increased risk of POP progression.
Entities:
Keywords:
Natural history; Observation; Pelvic organ prolapse; Risk factors
Authors: Kindra A Larson; Jiajia Luo; Kenneth E Guire; Luyun Chen; James A Ashton-Miller; John O L DeLancey Journal: Int Urogynecol J Date: 2011-11-09 Impact factor: 2.894
Authors: Jennifer M Wu; Catherine A Matthews; Mitchell M Conover; Virginia Pate; Michele Jonsson Funk Journal: Obstet Gynecol Date: 2014-06 Impact factor: 7.661
Authors: Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer Journal: Int Urogynecol J Date: 2009-11-25 Impact factor: 2.894
Authors: J Eric Jelovsek; Marie G Gantz; Emily Lukacz; Amaanti Sridhar; Halina Zyczynski; Heidi S Harvie; Gena Dunivan; Joseph Schaffer; Vivian Sung; R Edward Varner; Donna Mazloomdoost; Matthew D Barber Journal: Am J Obstet Gynecol Date: 2020-10-08 Impact factor: 8.661